Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Horizon Pharma enters into $300mm loan agreement to fund Vidara acquisition

Executive Summary

Horizon Pharma Inc. (therapeutics for pain, arthritis, and inflammation) entered into a five-year $300mm senior secured credit facility with affiliates of Citigroup Global Markets and Cowen & Co. The funds will support the cash portion of Horizon's $660mm cash/stock acquisition of Vidara Therapeutics Research Ltd.; the current agreement replaces one that Horizon had previously signed with Deerfield Management for $250mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Nonconvertible Debt

Related Companies